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This briefing paper is part of a series 
produced by Mentor ADEPIS on 
alcohol and drug education and 
prevention, for teachers and 
practitioners. 
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Questions for schools 
1. What are e-cigarettes? Are e-
cigarettes harmful? 
2. Is the use of e-cigarettes an 
issue among pupils?  
3. How should schools behave in 
relation to e-cigarettes? What 
issues should policies and 
guidance cover around the use of  
e-cigarettes by pupils, and by 
parents on school premises? 
What are e-cigarettes? 
Electronic cigarettes are battery-powered 
devices designed to deliver nicotine in a 
toxin-free vapour. These devices generally 
tend to simulate tobacco smoking. However, 
whilst many are designed and produced to 
look and feel like traditional cigarettes, 
others have different shapes and designs, 
and not all  produce vapour. 
 
Are e-cigarettes harmful?  
Unlike conventional cigarettes e-cigarettes 
do not generate smoke from combustion, 
instead they generate vapour that contains 
nicotine.  
“Nicotine is a highly addictive drug. It is both 
a stimulant and a sedative to the central 
nervous system. The ingestion of nicotine 
results in an almost immediate kick because 
it [...] stimulates the central nervous system, 
and other endocrine glands, which causes a 
sudden release of glucose. Stimulation is 
then followed by depression and fatigue, 
leading the abuser to seek more nicotine.” 1 
E-cigarettes generally contain nicotine, 
propylen glycol (used to create the artificial 
vapour), glycerin, water, and flavourings. 
The amount of nicotine contained in e-
cigarettes can vary between and within 
brands, from nicotine-free products through 
to high doses of nicotine. However, there is 
E-shisha products:  
Some products are currently being 
marketed as e-shisha. E-shisha 
products, like e-cigarettes, consist of 
devices that vaporise liquid containing 
different types of chemical flavourings 
and a solvent. E-shisha are normally 
described as nicotine free. However, the 
e-liquid or ’e-juice‘, which is normally 
sold separately from the device, may or 
may not contain nicotine. Like e-
cigarettes they are available in a range 
of nicotine concentrations, either 
rechargable or disposable, and with a 
range of flavours. There is therefore no 
meaningful distinction between e-shisha 
products and e-cigarettes, other than 
marketing. When we refer to e-
cigarettes in this briefing paper, we 
therefore include e-shisha pens and 
similar products.  
E-cigarettes and Nicotine Containing Products  
 
mentor-adepis.org 2 
very little quality control which often means 
there is difference between what is on the 
label and what is delivered to the user – 
with nicotine concentration generally lower 
than claimed. Other factors will also 
influence the amount of nicotine ingested, 
such as the design of the product, the way 
the product is used (longer or shorter puffs 
etc), and the individual’s metabolism. 
 
Is the use of e-cigarettes an issue 
among pupils?  
 Are e-cigarettes becoming more popular 
among young people? 
 Will they be an issue among school 
pupils? 
A recent survey suggests that the use of e-
cigarettes among children and young 
people is rare.2   
Only 1 in 10 16-18 year olds who had heard 
of e-cigarettes (1 in 20 among 11-15 year 
olds) had “tried e-cigarettes once or twice”; 
and only 1% 16-18 year olds (0% 11-15 
year olds) were using e-cigarettes more 
than once a week. 
It appears that young people’s use of e-
cigarettes is mainly amongst those who are 
already smoking or have previously 
smoked.  Among young people who have 
never smoked only 1% have “tried e-
cigarettes once or twice”, none report 
continued e-cigarette use or expect to try an 
e-cigarette soon. 
The survey also showed that knowledge 
and general understanding of e-cigarettes 
among children and young people is mixed.  
74% of respondents correctly understood e-
cigarettes to be safer than conventional 
cigarettes and half (51%) believed them to 
contain nicotine – which many, but not all, of 
the products do.  
 
How should schools behave in 
relation to e-cigarettes? 
The anti-smoking campaign ASH 
www.ash.org.uk has produced detailed 
guidelines on whether e-cigarettes should 
be prohibited in public places. They are not 
specific to schools but the framework may 
be useful. Key questions for decision 
makers include:  
 What are the issues you are trying to 
deal with? 
 What do you think you need to control? 
 Do you have concerns about the 
possibility of harm from NCPs?3  
 
What issue you are trying to deal 
with? What do you need to control?  
Most schools have a smoke-free policy that 
covers the entire campus. Outside of 
schools some public places have recently 
decided to include e-cigarettes in their 
smoke-free policies to avoid confusion in 
distinguishing an electronic device from a 
conventional cigarette. Where schools have 
yet to decide their policy they might want 
consider implementing the same action to 
avoid confusion among pupils and staff.  
The following questions may help:  
 Is the policy extended to all adults, 
members of staff and site visitors? 
 Can the school provide clear information 
about the difference in harm between 
tobacco products and e-cigarettes? 
 Should the school provide standard 
information to parents about using 
alternative nicotine containing products, 
so as not to undermine their efforts to 
quit or reduce smoking?  
 
Do you have concerns about the 
possibility of harm from e-
cigarettes? 
E-cigarettes substantially reduce exposure 
to all tobacco smoke toxicants. There are no 
circumstances in which it would be safer to 
smoke than to use an e-cigarette. However, 
the extent of nicotine uptake and safety of e
-cigarettes has not yet been established and 
although at present we have little evidence 
of harm, this could emerge over time. 
The lack of regulation and the consequent 
inconsistency in safety and quality controls 
among different products represent the 
biggest identified safety concerns. 
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In June 2013 the Medical and Healthcare 
Products Regulatory Agency (MHRA) 
announced that they would regulate all NCP 
as medicines by 2016 to “ensure that high-
quality products can be made available to 
help support smokers to cut down their 
smoking and to quit.”4  
Meanwhile, the MHRA has said that, as a 
result of concerns over the quality of 
currently unregulated products, e-cigarettes 
cannot be recommended for use at 
present. 
They say: 
“Testing data confirm that nicotine levels 
can vary considerably from the labelled 
content and the amount of nicotine per 
product can differ from batch to batch. In 
terms of how well Nicotine Containing 
Products work, there can be widely differing 
amounts of nicotine from the same format 
with one form delivering what could be an 
effective therapeutic dose, another a 
'placebo' dose. With regards to safety, toxic 
elements may be included at unexpectedly 
high doses which could produce adverse 
effects, particularly in vulnerable patient 
groups”5   
Harm related to conventional smoking is 
normally divided into three categories: 
Direct harm, indirect harm, and role models. 
The same framework can be applied to e-
cigarettes. 
Direct harm: Testing by the MHRA has 
found potentially harmful chemicals 
contained in some devices. However, the 
findings have been inconsistent and there is 
not yet strong enough evidence to consider 
e-cigarettes harmful. Although current 
findings do not present any cause for major 
health concern, the MHRA stressed the 
need to regulate NCPs for safety reasons.  
Indirect harm: There are currently no 
scientific studies proving harm from second 
hand e-cigarette vapour. Reviews 
conducted by the MHRA have found 
potentially harmful constituents in vapour 
released by e-cigarettes, nevertheless it is 
important to note that these have been 
estimated to be less harmful than 
conventional cigarettes, and in one case as 
non-harmful to human health. 
Role models: Some fear the potential of e-
cigarettes in re-normalising cigarette use, 
both through marketing and observed 
behaviour. Some also see e-cigarettes as a 
potential gateway to conventional 
cigarettes, although at present there is no 
consistent evidence pointing in that 
direction. Others argue that children 
witnessing adults choosing e-cigarettes over 
conventional cigarettes might de-normalise 
tobacco use in the longer term.  Again there 
is no clear evidence for this theory. 
 
Curriculum 
 How can e-cigarettes be included in the 
PSHE or science curriculum? 
 How can pupil’s current knowledge of e-
cigarettes be assessed? 
 
School policies, searching and 
confiscation 
A rigorous school policy should set out the 
school’s approach to e-cigarettes and other 
non-licensed NCPs. Both pupils and staff 
should be aware of how these products are 
regarded and treated by the school; and 
whether possession and use of those 
devices by pupils, staff and visitors is 
allowed on school premises. 
Should e-cigarettes or other non licensed 
NCPs be prohibited, schools must ensure 
they follow the guidance produced by the 
Department for Education when exercising 
their powers to search and confiscate items 
from pupils.6 
E-cigarettes do not contain tobacco; 
therefore schools have problems 
categorising them as ‘tobacco products’. 
ADEPIS asked the Department for 
Education for further clarification and were 
told that, although their guidance only lists 
some prohibited products, all schools and 
FE colleges would be entitled to include e-
cigarettes to their list of prohibited items 
should they choose.  
 
What advice does the National 
Institute for Care and Health 
Excellence (NICE) give? 
NICE guidance on smoking cessation 
suggests that young people (aged 12-17) 
are offered clear information, advice and 
support on how to stop smoking; and they 
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are encouraged to use local NHS Stop 
Smoking Services before considering the 
use of Nicotine Replacement Therapies 
(patches, gum etc.). Professional judgement 
must be used to decide whether or not to 
offer NRT to pupils showing noticeable 
nicotine dependence; and if prescribed, 
whether this should be offered as part of a 
supervised regime.7 
Nevertheless NICE guidance makes clear 
that all forms of licensed NRT can be used 
for young people aged 12–17 who smoke, 
as long as they have been made aware of 
the risks and benefits of the products.  
None of the above guidance currently 
includes e-cigarettes, as they are not 
licensed and should not be treated as 
Nicotine Replacement Therapy until medical 
regulation comes into effect. It is also likely 
that when e-cigarettes are licensed and 
regulated they will carry age-related sale 
restrictions.   
 
Conclusion  
Whilst there is lack of clear information and 
regulation around e-cigarettes and other 
non-licensed Nicotine Containing Products, 
in the absence of firm guidelines, schools 
are perfectly entitled to prohibit the use of e-
cigarettes and e-shisha products.  
Given that many adults appear to be using e
-cigarettes to quit or cut down smoking, 
schools will want to consider whether a 
complete ban could have the unintended 
consequence of adults who are trying to 
stop smoking failing to quit.  
We strongly recommend reading the 
different resources and recommendations 
produced by ASH, NICE and the MHRA, 
links for which are given below. 
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